Citryll has translated a deep understanding of the extracellular trap (ET) pathway to therapeutically address its central role in a broad range of immune-mediated inflammatory diseases (IMIDs). With a unique dual mode of action, the company’s lead antibody, CIT-013, has reached the clinic by demonstrating a precise and powerful ability to control ETs and ETosis. Citryll is initially developing CIT-013 as a novel drug for rheumatoid arthritis and hidradenitis suppurativa, which may serve as enabling indications for a wide spectrum of IMIDs.
| Website | http://www.citryll.com |
| Employees | 38 (28 on RocketReach) |
| Founded | 2015 |
| Technologies |
JavaScript
,
HTML
,
PHP
+8 more
(view full list)
|
| Industry | Biotechnology Research, Neuroscience, Pharmaceuticals, Biotechnology, Science and Engineering |
| Keywords | Antibody Therapeutics, Inflammatory Diseases, Drug Development, Therapeutic Antibodies, Immunology, Pharmaceutical Research, Inflammation Treatment, Protein Therapeutics, Autoimmune Diseases, Biotechnology, Novel Therapeutics, Clinical Development, Targeted Therapy, Precision Medicine, Immune System, Biopharma, Clinical Trials |
| Competitors | Novartis, Regeneron, Kite Pharma, bluebird bio, Adaptimmune, Immunovant, Zymeworks Inc., Celyad Oncology, NantKwest, OncoSec +37 more (view full list) |
Looking for a particular Citryll employee's phone or email?
Citryll Questions
Sjoerd van Gorp is the COO and CFO of Citryll.
28 people are employed at Citryll.
Top Citryll Employees
-
Sjoerd van Gorp
COO and CFO at Citryll
Utrecht, Netherlands33 -
5+5+
-
Tim Schenk
Chief Business Officer at Citryll
Amsterdam, NH, NL1 -
Maarten Kraan
Chief Medical Officer at Citryll
Utrecht, UT, NL35 -
22
-
Mark Krebs
CMC Director at Citryll
Leiden, ZH, NL22 -
Fiona MacLaughlin
Non Executive Director at Citryll
United Kingdom32 -
Maarten van der Linden
Director Disease Biology at Citryll
Sint-Oedenrode, NB, NL1 -
2
Related Companies
